News

The randomized, double-blind clinical trial is designed for evaluating Endocyte’s vintafolide drug in combination with DOXIL compared to DOXIL plus placebo for the treatment of folate-receptor positive platinum-resistant

ETI-204 is a humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins. Under the grant, Department

As part of the CRADA, the biomedical company will assess the safety and efficacy of Oxycyte, a perfluorocarbon-based drug candidate, as well as hemoglobin-based oxygen carriers (HBOC) as

Based on the health concerns for Baby Boomers and aging adults,Vitamins A&D is used for promoting strong bones and healthy eyes. In general, Vitamin A is used for

Patients who have not been previously treated with a direct ALK inhibitor, such as crizotinib, are being enrolled for both trials. In the first trial, CHIARA trial (CHaperone

The OX1 patent relates to a new salt form found to be useful to increase the purity of the compound during manufacture. The company has also received a

The patent covers palifosfamide compositions, formulations, methods of use and methods of manufacture, which now includes issued patents in the US, Australia, Europe, New Zealand and South Africa.

The new US based company has entered into development, licensing and manufacturing agreements with ProMetic. Under the agreements, ProMetic has granted NantPro rights to its Plasma Protein Purification

A single administration of NX-1207 2.5mg has produced on average improvements in the standardised BPH symptom score (8-10 points at 90 days) that were approximately double that reported